Miller Huang

Miller Huang received his Bachelor’s degree in Bioengineering from the University of California, Berkeley and his PhD in Molecular Pathology from the University of California, San Diego. Under the guidance of Dr David A Cheresh at UCSD, Miller identified downstream effectors of EGFR-mediated metastasis in pancreatic cancer. Miller then trained with Dr William A Weiss at the University of California, San Francisco and developed new models for medulloblastoma and neuroblastoma. In 2019, Miller joined Children’s Hospital Los Angeles to utilize these new model systems in his own laboratory to discover genetic drivers and identify therapeutic targets for medulloblastoma and neuroblastoma.